Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01266928Phase 3Completed
A Phase 3 trial of ascorbic acid, alpha-tocopherol in preterm premature rupture of membranes (pPROM), sponsored by Erzincan Military Hospital. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01266928.